NCT02879643: Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL |
|
|
| Recruiting | 1 | 36 | Canada, US, RoW | Marqibo | Therapeutic Advances in Childhood Leukemia Consortium, Spectrum Pharmaceuticals, Inc | ALL, Childhood, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia, Acute | 08/21 | 12/22 | | |